A Comparative Clinical Study of Bhallataka-snuhi lepa versus Kakodumbradi lepa in the Management of Shvitra(Vitiligo): A Randomized controlled Trial

A Comparative Clinical Evaluation of Dhatri-Khadira kwath with Bhallataka-Snuhi lepa versus Dhatri-Khadira kwath with Kakodumbradi lepa in the management of Shvitra(Vitiligo) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106164

Enrollment

Registered

2026-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed case of uncomplicated vitiligo either segmental or generalized involving both of sex were registered 2. Patients having age between 16 to 60 years 3. Patients with chronicity of less than 10 years 4. Lesion with positive wood s lamp test 5. Presence of Dushi/Gara Visha as an etiology (By Questionnaire) 6. Assessment criteriya for surface area mild and moderate 7. Assessment criteriya for number of patches mild and moderate

Exclusion criteria

Exclusion criteria: 1. Chronicity more than 10 years 2. Vitiligo patient associated with other disease like hypothyroidism Anemia diabetes hypertension tuberculosis RA SLE etc 3. Vitiligo patches that rapidly spread and become associated with redness blister formation and itching during therapy or as such 4. Patches due to burning, chemical (Deodrant, perfume and any beauty products etc..) 5. Gravid and lactating women 6. Lesion at Guhyanga (genital organ), Pani-padatala (palms and soles) Oshtha (lips) Ekanga (involving an entire organ) Sarvanga (generalized lesion) 7. Uncooperative patients

Design outcomes

Primary

Measure	Time frame
To assess improvement in sign and symptoms of Shvitra(Vitiligo) i.e.Change in colour, reduction in surface area and no. of patches at the affected site.Timepoint: 90 days	—

Secondary

Measure	Time frame
1.To assess the clinical effectiveness of Bhallataka-snuhi lepa with Dhatri-Khadira Kwath in reducing the severity of Shvitra patients. 2.To evalute the clinical efficacy of Kakodumradi lepa with Dhatri-Khadira Kwath in treatment of Shvitra. 3.To compare the improvement in Shvitra s patients treated with Bhallataka-Snuhi lepa with Dhatri-Khadira Kwath versus Kakodumbradi lepa with Dhatri-Khadira KwathTimepoint: 90 days	—

Measure

Time frame

1.To assess the clinical effectiveness of Bhallataka-snuhi lepa with Dhatri-Khadira Kwath in reducing the severity of Shvitra patients. 2.To evalute the clinical efficacy of Kakodumradi lepa with Dhatri-Khadira Kwath in treatment of Shvitra. 3.To compare the improvement in Shvitra s patients treated with Bhallataka-Snuhi lepa with Dhatri-Khadira Kwath versus Kakodumbradi lepa with Dhatri-Khadira KwathTimepoint: 90 days

—

Countries

India

Contacts

Public ContactDr.(Prof) Jai Kumar Singh

Government Ayurvedic College and Hospital,Kadamkuan patna.

Jai.kumar1966@rediffmail.com9199373517

Outcome results